NDC 35356-721

Carisoprodol

Carisoprodol

Carisoprodol is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Lake Erie Medical & Surgical Supply Dba Quality Care Products Llc. The primary component is Carisoprodol.

Product ID35356-721_44f24461-7ff8-4cda-a9cd-fda0fb48e2ee
NDC35356-721
Product TypeHuman Prescription Drug
Proprietary NameCarisoprodol
Generic NameCarisoprodol
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2011-12-31
Marketing CategoryANDA / ANDA
Application NumberANDA087499
Labeler NameLake Erie Medical & Surgical Supply DBA Quality Care Products LLC
Substance NameCARISOPRODOL
Active Ingredient Strength350 mg/1
Pharm ClassesCentrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC]
DEA ScheduleCIV
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 35356-721-01

120 TABLET in 1 BOTTLE (35356-721-01)
Marketing Start Date2011-12-31
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 35356-721-00 [35356072100]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA087499
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-12-31
Marketing End Date2013-12-31

NDC 35356-721-90 [35356072190]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA087499
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2011-12-31
Marketing End Date2019-06-30

NDC 35356-721-20 [35356072120]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA087499
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2011-12-31
Marketing End Date2013-12-31

NDC 35356-721-50 [35356072150]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA087499
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-12-31
Marketing End Date2013-12-31

NDC 35356-721-01 [35356072101]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA087499
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2011-12-31
Marketing End Date2019-06-30

NDC 35356-721-10 [35356072110]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA087499
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-12-31
Marketing End Date2013-12-31

NDC 35356-721-15 [35356072115]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA087499
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-12-31
Marketing End Date2013-12-31

NDC 35356-721-30 [35356072130]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA087499
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2011-12-31
Marketing End Date2019-06-30

NDC 35356-721-14 [35356072114]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA087499
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-12-31
Marketing End Date2013-12-31

NDC 35356-721-60 [35356072160]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA087499
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2011-12-31
Marketing End Date2019-06-30

NDC 35356-721-40 [35356072140]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA087499
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2011-12-31
Marketing End Date2013-12-31

Drug Details

Active Ingredients

IngredientStrength
CARISOPRODOL350 mg/1

OpenFDA Data

SPL SET ID:9932a519-0ea2-4b52-9d93-cd0f5f63d592
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 197446

    • Pharmacological Class

    • Centrally-mediated Muscle Relaxation [PE]
    • Muscle Relaxant [EPC]

    NDC Crossover Matching brand name "Carisoprodol" or generic name "Carisoprodol"

    NDCBrand NameGeneric Name
    0143-1176CarisoprodolCarisoprodol
    0143-9749CarisoprodolCarisoprodol
    0591-5513CarisoprodolCarisoprodol
    0603-2582CarisoprodolCarisoprodol
    10544-033CarisoprodolCarisoprodol
    10544-088CARISOPRODOLCARISOPRODOL
    10544-132CarisoprodolCarisoprodol
    12634-437CarisoprodolCarisoprodol
    16571-780carisoprodolcarisoprodol
    16571-781carisoprodolcarisoprodol
    16714-510CarisoprodolCarisoprodol
    29033-207CarisoprodolCarisoprodol
    29033-214CarisoprodolCarisoprodol
    33261-387CarisoprodolCarisoprodol
    33358-064CARISOPRODOLCARISOPRODOL
    35356-721CarisoprodolCarisoprodol
    42254-068CarisoprodolCarisoprodol
    42543-434CARISOPRODOLCARISOPRODOL
    42543-700CARISOPRODOLCARISOPRODOL
    43063-302CarisoprodolCarisoprodol
    43063-824CarisoprodolCarisoprodol
    43353-102CARISOPRODOLCARISOPRODOL
    68071-2188CarisoprodolCarisoprodol
    68071-4263CarisoprodolCarisoprodol
    68071-4112CarisoprodolCarisoprodol
    68071-4610CARISOPRODOLCARISOPRODOL
    68387-600CarisoprodolCarisoprodol
    68788-6866CarisoprodolCarisoprodol
    68788-2582CarisoprodolCarisoprodol
    68788-9976CARISOPRODOLCARISOPRODOL
    70518-0704CarisoprodolCarisoprodol
    70518-1092CarisoprodolCarisoprodol
    70518-1401CarisoprodolCarisoprodol
    71335-0131CarisoprodolCarisoprodol
    71205-241CARISOPRODOLCARISOPRODOL
    71335-0407CarisoprodolCarisoprodol
    71335-0516CARISOPRODOLCARISOPRODOL
    71335-0693CARISOPRODOLCARISOPRODOL
    71610-097CARISOPRODOLCARISOPRODOL
    75921-513CARISOPRODOLCARISOPRODOL
    76333-135CarisoprodolCarisoprodol
    50090-0281CarisoprodolCarisoprodol
    49999-064CarisoprodolCarisoprodol
    50090-0280CarisoprodolCarisoprodol
    50090-2530CarisoprodolCarisoprodol
    50090-3232CarisoprodolCarisoprodol
    50090-3048CARISOPRODOLCARISOPRODOL
    50090-3211CarisoprodolCarisoprodol
    50090-2771CarisoprodolCarisoprodol
    50228-109CARISOPRODOLCARISOPRODOL
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.